Anti-Respiratory Syncytial Virus M2-1 Protein antibody [EPR28649-58],Abcam,AB323319
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human respiratory syncytial virus A (strain A2)
Application
I-ELISA, ICC/IF, WB, IHC-P
Platform ID
BAB955575570
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Specifications
Scientific Background
Target data Acts as a tetrameric transcription processivity factor that binds in a competitive manner to RNA and the phosphoprotein (P) to prevent premature termination during transcription (PubMed : 19386701, PubMed : 22675274). Transcription anti-terminator that enhances readthrough of intergenic junctions during viral transcription (PubMed : 10364337, PubMed : 27194388, PubMed : 8552680, PubMed : 9420254). Preferentially binds to poly(A)-rich sequences (PubMed : 24434552). Plays a role in the association of the matrix protein with the nucleocapsid, which initiates assembly and budding (PubMed : 18579594). Also, can activate host NF-kappa-B through association with host RELA (PubMed : 15629770). See full target information M2-1
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
- Products>Trial Size Antibodies
Please provide the required information below so that we can quickly source your products.